In a study exploring the effects of HDAC1 inhibitor 4b, researchers found that within fly, cell, and mouse models of HD, HDAC3 was selectively targeted, and the inhibitor was able to suppress HD-related symptoms [95]. The gene discussed is HDAC1; the disease is Huntington disease.